Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06016127 · ClinicalTrials.gov registry record · NA

Cryoneurolysis for Facet Mediated Chronic Low Back Pain

A NA study of Low Back Pain and Facet Joint Pain, sponsored by Medical Pain Management Services, P.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06016127 is a NA study of Low Back Pain and Facet Joint Pain that has completed, run by Medical Pain Management Services, P. The registered enrollment target is 30 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06016127, a NA study of Low Back Pain and Facet Joint Pain, has completed, sponsored by Medical Pain Management Services, P.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a single-center, randomized, pilot study in adult subjects with facet mediated CLBP. Thirty (30) subjects are planned for initial enrollment and will be randomized 1:1 to receive ioveraº medial branch cryoneurolysis or radiofrequency ablation.

Interventions

  • DEVICE iovera system
  • DEVICE Radiofrequency ablation

Study Locations (1)

New York

  • The Albany & Saratoga Centers For Pain Management - Saratoga Springs

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-06-18
Est. Completion 2023-10-23
Phase NA

What the Registry Record Tells You About NCT06016127

The ClinicalTrials.gov registry entry for NCT06016127 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower). The listed sponsor is Medical Pain Management Services, P, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which iovera system is the first listed.

NCT06016127 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06016127 about?

NCT06016127 is a clinical study titled "Cryoneurolysis for Facet Mediated Chronic Low Back Pain". This is a single-center, randomized, pilot study in adult subjects with facet mediated CLBP. Thirty (30) subjects are planned for initial enrollment and will be randomized 1:1 to receive ioveraº medial branch cryoneurolysis or radiofrequency ablation.

What is the current status of trial NCT06016127?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-06-18. Estimated completion is 2023-10-23.

What conditions does trial NCT06016127 study?

This clinical trial studies the following conditions: Low Back Pain, Facet Joint Pain.

What interventions are being tested in trial NCT06016127?

The interventions under investigation include: iovera system (DEVICE), Radiofrequency ablation (DEVICE).

Who is sponsoring clinical trial NCT06016127?

This trial is sponsored by Medical Pain Management Services, P, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06016127 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.